CReDO Science is led by Ethan Russo, MD, a board-certified neurologist and psychopharmacology researcher and formulator in the medical cannabis field.
Verdant Nature LLC (Chicago), a vertically integrated producer of phytocannabinoid and cannabidiol-rich (CBD) hemp oil products, has partnered with CReDO Science LLC, a biopharma company commercializing patented products from the cannabis plant. The companies will work together to develop proprietary hemp-derived formulations for clients.
Verdant Nature manufactures the Verdant Oasis ingredient brand. Its products are available in USDA NOP–organic and conventional formats (oil, powder, and water-dispersible forms).
CReDO Science is led by Ethan Russo, MD, a board-certified neurologist and psychopharmacology researcher and formulator in the medical cannabis field. He is the author of more than 50 peer-reviewed journal articles and seven books on cannabis and the endocannabinoid system, and served as a medical monitor and study physician on 23 clinical trials for cannabis-based pharmaceuticals.
“Having Dr. Russo work with Verdant Nature R&D catapults our ability to support our clients in crafting distinctive endocannabinoid system–support products,” stated Carl Germano, CNS, CDN, vice president of Verdant Nature, in a press release. “Dr. Russo’s impeccable credentials and expertise in cannabinoid medicine will provide the guidance needed to help our clients stand out among the single magic-bullet CBD products pervading the marketplace.”
Prinova acquires Aplinova to further increase its footprint in Latin America
April 7th 2025Prinova has recently announced the acquisition of Brazilian ingredients distributor Aplinova, which is a provider of specialty ingredients for a range of market segments that include food, beverage, supplements, and personal care.